CA19.9 near me in Sonipat
Understanding CA19.9 in Sonipat
What is CA19.9 in Sonipat?
A CA19.9 test measures the levels of a specific protein called cancer antigen (CA19.9) in the blood. This protein is associated with certain types of cancer, most notably affecting the pancreas. Elevated levels of CA 19.9 in the blood are frequently associated with pancreatic tumors. However, elevated levels can also be seen in various other cancers, including colorectal, gastric, hepatobiliary, and ovarian cancer, and in some non-cancerous conditions such as pancreatitis, cirrhosis, and benign gallbladder disease. This test is available at an affordable price in Sonipat with Tata 1mg labs.
This test is not standalone; other confirmatory procedures, such as imaging studies or biopsies, are often necessary to validate cancer diagnosis. CA19.9 test, when integrated into a comprehensive clinical approach, contributes significantly to the timely identification and treatment of cancers, ultimately impacting treatment outcomes.
What does CA19.9 measure?
A CA19.9 test measures the level of a specific tumor marker called CA 19.9 in the blood, often associated with gastrointestinal cancers, particularly pancreatic cancer. This biomarker is produced by certain cells in the body, specifically epithelial cells. These cells are found in various tissues, including the gastrointestinal tract. Elevated levels of CA 19.9 are often associated with cancers that involve these tissues, such as pancreatic, colorectal, and gastric cancers. However, CA 19.9 can also be produced by non-cancerous conditions, impacting its specificity as a diagnostic marker. For a comprehensive evaluation, it is advised to consider other diagnostic tests in conjunction with a CA19.9 test and consult a doctor for a proper understanding of the test results.
Answers to Patient Concerns & Frequently Asked Questions (FAQs) about CA19.9 in Sonipat
Frequently Asked Questions about CA19.9 in Sonipat
Q. When should I get a CA19.9 test?
Q. Is there any risk associated with a CA19.9 test?
Q. Is a CA19.9 test a definitive diagnostic test for pancreatic cancer?
Q. Can I schedule an online booking for a CA19.9 test in Sonipat near me?
Q. Is home sample collection facility available for a CA19.9 test in Sonipat with Tata 1mg Labs?
Q. What is the price of a CA19.9 test at Tata 1mg Labs in Sonipat?
Q. How can I get my CA19.9 test report from Tata 1mg?
Q. What is the estimated turnaround time for the results of a {test-name} test in Sonipat?
Book a CA19.9 test at home near me
References
- CA 19-9 [Internet]. Rochester, NY: University of Rochester Medical Center; [Accessed 20 Dec. 2023]. Available from: https://www.urmc.rochester.edu/encyclopedia/content.aspx?contenttypeid=207&contentid=ca_19_9
- Ballehaninna UK, Chamberlain RS. The clinical utility of serum CA 19-9 in the diagnosis, prognosis and management of pancreatic adenocarcinoma: An evidence based appraisal. J Gastrointest Oncol. 2012 Jun;3(2):105-19. [Accessed 20 Dec. 2023]. Available from: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3397644/
- Ballehaninna UK, Chamberlain RS. Serum CA 19-9 as a Biomarker for Pancreatic Cancer-A Comprehensive Review. Indian J Surg Oncol. 2011 Jun;2(2):88-100. [Accessed 20 Dec. 2023]. Available from: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3244191/
- Puckett Y, Garfield K. Pancreatic Cancer. [Updated 2022 Sep 26]. In: StatPearls [Internet]. Treasure Island (FL): StatPearls Publishing; 2023 Jan-. Available from: https://www.ncbi.nlm.nih.gov/books/NBK518996/
- Vincent A, Herman J, Schulick R, Hruban RH, Goggins M. Pancreatic cancer. Lancet. 2011 Aug 13;378(9791):607-20. [Accessed 20 Dec. 2023]. Available from: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3062508/
- Zhao Z, Liu W. Pancreatic Cancer: A Review of Risk Factors, Diagnosis, and Treatment. Technol Cancer Res Treat. 2020 Jan-Dec;19:1533033820962117. [Accessed 20 Dec. 2023]. Available from: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7768873/
- Wu E, Zhou S, Bhat K, Ma Q. CA 19-9 and pancreatic cancer. Clin Adv Hematol Oncol. 2013 Jan;11(1):53-5. PMID: 23596673; PMCID: PMC3633106. [Accessed 20 Dec. 2023]. Available from: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3633106/
- Ballehaninna UK, Chamberlain RS. Serum CA 19-9 as a Biomarker for Pancreatic Cancer-A Comprehensive Review. Indian J Surg Oncol. 2011 Jun;2(2):88-100. [Accessed 20 Dec. 2023]. Available from: https://pubmed.ncbi.nlm.nih.gov/22693400/
- Wang F, Herrington M, Larsson J, Permert J. The relationship between diabetes and pancreatic cancer. Mol Cancer. 2003 Jan 6;2:4. [Accessed 20 Dec. 2023]. Available from: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC149418/
Other tests
